Business Wire

Mary Kay Inc. Champions Business Excellence, Ethics and Social Responsibility in Direct Selling Sector and Beauty Industry, Reaps Rewards in Europe

10.7.2019 10:00:00 EEST | Business Wire | Press release

Share

On May 22, the global beauty company announced Chairman and CEO David Holl is among the top ten most reputable chief executives in the world according to Reputation Institute’s 2019 CEO RepTrak® study. Reputation Institute, the world’s leading provider of reputation intelligence, measured the reputation of more than 140 global CEOs and canvassed more than 230,000 individual ratings among the informed public. The study was conducted in January and February of this year.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190710005268/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Tara Eustace, President of the Mary Kay Europe Region. (Photo: Mary Kay Inc.)

According to Kylie Wright-Ford, CEO at Reputation Institute, acting responsibly, behaving ethically and caring about social issues are the most important drivers of CEO reputation. In fact, according to Reputation Institute’s findings, CEOs are more likely to be judged on ethics versus profit margins. In this way, the perception of CEOs and the companies they lead are directly correlated.

This meaningful recognition echoes the series of milestones reached by Mary Kay in Europe over the past months. In 2018 and 2019, Mary Kay's Europe Region earned over 90 product and industry awards and counting — a testament to Mary Kay’s mission to enrich women’s lives, offer science-driven products women love and a long-standing commitment to give back to the community.

“In a highly competitive environment, Mary Kay’s business values stand out around the world, and shine in Europe,” said Tara Eustace, President of the Mary Kay Europe Region. “Each of these awards materialize the truth of our commitment; they also provide Independent Beauty Consultants in Europe pride to celebrate with their customers and share product news and updates, while reinforcing confidence in the brand,” added Eustace.

Recent awards include:

Excellence in Direct Selling
Seldia, the European Direct Selling Association, recently recognized Mary Kay Europe as “Best Company of the Year” at its 2018 Astra Awards. In July 2019, Mary Kay Belarus received the “Direct Sales Cosmetic Company Number One Award” from the “Number One” annual national awards. In June 2019, Mary Kay Ukraine was recognized as “Number 1 Direct Selling Cosmetic Brand” in the “Favor of Success” survey. Mary Kay Spain has been the 2014, 2015, 2016 and 2017 “Number 1 Direct Selling Cosmetic Company” according to the Commercial Register data.

Excellence in Women’s Leadership
In April 2019, Mary Kay Russia’s General Manager, Alla Sokolova, received the "Manager of the Year Award” from Russian Business Guide's People of the Year, recognizing her contribution to the development of the Russian economy and entrepreneurship in Russia.

In 2016, 2017, and 2018, Mary Kay Spain's General Manager, Gema Aznar, was featured in YoDona magazine's annual “500 Most Influential Women in Spain” list highlighted in its special edition called “Female Power.”

Excellence in Women’s Entrepreneurship and Empowerment
On May 24, the “Secrets of Big Business with Mary Kay®” program created by Mary Kay Russia was recognized as the “2019 Best Social Project of Russia Award” in the “Social Entrepreneurship” category. In November 2018, Mary Kay Russia had already earned the “Woman Who Matters Award” rewarding women’s entrepreneurship for the “Secrets of Big Business with Mary Kay®” program. “Woman Who Matters” identifies the best initiatives, practices and programs of Russian companies aimed at women’s support.

Mary Kay Russia also received the “2018 Best Social Project of Russia Award” for its “Beauty of Confidence” campaign and Skin Care Labs. The Best Russian Social Project annual contest was held in May, with more than 70 companies submitting their social projects. The program was created to support the Russian government’s plans to strengthen social policies.

Mary Kay Belarus received a “2018 Brand of the Year” Silver Medal in the Social Responsibility category for its socially active position. The award was a result of the implementation of the “Beauty That Counts” program and the company's contribution to the development of women's entrepreneurship in Belarus.

Mary Kay UK received the “Company with Heart Award” at the 2018 UK Pride of Direct Selling Awards for their partnership with the Look Good, Feel Better charity. “The Company with Heart Award” is awarded to the company which has gone the extra mile to make a charitable impact through its philanthropic activities and community engagement work.

Excellence in Digital Training
Mary Kay was recognized in the “2019 Spring Omni Awards” with a coveted gold ranking in the Educational category for its innovative Link & Learn™ sales education system. The e-learning platform hosts a robust learning curriculum designed to amplify educational support for the independent sales force and increase their business success. It also connects Mary Kay Independent Beauty Consultants to a learning community based on content, accessibility and localization. Mary Kay’s Link & Learn was also awarded a “2018 Technology Excellence Award” from the Brandon Hall Group last January with a Bronze Medal in the category of Best Advance in Learning Management Technology for External Training.

Excellence in Digital & Printed Tools
In April, Mary Kay Russia’s MirrorMe App won the "2019 Best Corporate Media Award” in the "Client Media: Web Media” category. With the Mary Kay® MirrorMe mobile application, anyone can create beautiful makeup without any makeup tools.

Mary Kay Russia’s “Applause” magazine for Independent Beauty Consultants won two awards in 2018: the "Media Leader Award” in the category "Best Corporate Magazine" and the “Silver Threads Award” in the category “Best Corporate Edition.”

Excellence as an Employer
Mary Kay Spain and Mary Kay Poland earned the “2018 AON Best Employers Award,” recognizing organizations demonstrating excellence in the workplace.

Product Excellence
With more than 1,500 patents and a team of scientists dedicated to producing innovative products backed by proven results, Mary Kay® products garnered more than 40 awards in 2018 and already 22 in 2019. Among the products distinguished by the Beauty industry and consumers, Mary Kay TimeWise Miracle® 3D set, TimeWise Repair® Lifting Bio-Cellulose Mask, TimeWise® Vitamin C Activating Squares, and Oil-Free Eye Makeup Remover, were the most rewarded.

About Mary Kay
One of the original glass ceiling breakers, Mary Kay Ash founded her beauty company more than 55 years ago with three goals: offer rewarding opportunities for women, manufacture irresistible products and make the world a better place. That dream has blossomed into a multibillion-dollar company with millions of independent sales force members in nearly 40 countries. Mary Kay is dedicated to researching the science behind beauty and to manufacturing cutting-edge skin care, color cosmetics, fragrances and nutritional supplements. Through the Mary Kay Foundation℠, the company has awarded more than $78 million to cancer research and domestic violence shelters. Mary Kay Ash’s original vision continues to shine—one lipstick at a time.

About Reputation Institute
Reputation Institute helps leaders at the world’s largest companies build credibility with the people that matter most to them by delivering data-driven insights about how they are truly perceived. We do this with RepTrak®, an unrivaled technology that provides actionable insights across industry, competitor, and company analysis. Past and present clients have included Whirlpool, Barnes & Noble,​The Estée Lauder Companies, ​JP Morgan Chase & Co., LEGO, P&G, Cisco, and Telefonica, among many others.

About Seldia
Seldia recognizes the outstanding achievements of organizations that demonstrate excellence in empowerment, entrepreneurship and a commitment to producing best-in-the-industry products. Representing 28 national direct selling associations and 20 member-companies throughout Europe, Seldia’s mission is to promote the interest of national direct selling associations and direct selling companies in the European footprint. “Best Company of the Year” recognizes the corporate member that best raises awareness of the direct selling method of distribution, promotes the method’s socio-economic benefits and demonstrates a strong commitment to supporting the mission of Seldia.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Mary Kay Inc. Corporate Communications
marykay.com/newsroom
972.687.5332 or media@mkcorp.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Galderma Receives U.S. FDA Approval for Differin ® Epiduo ® Acne Gel Prescription-to-OTC Switch22.5.2026 19:25:00 EEST | Press release

Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) use in ages 12 years and older, marking a significant Prescription-to-OTC transition in acne care. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522074280/en/ The U.S. FDA approves Differin® Epiduo® Acne Gel Prescription-to-OTC switch This milestone represents yet another example of Galderma’s unique Integrated Dermatology strategy, demonstrating how proven innovations from its Therapeutic Dermatology portfolio can further strengthen its Dermatological Skincare offerings. The Prescription‑to‑OTC transition highlights Galderma’s scale and expertise in successfully commercializing dermatology innovations across the full spectrum of acne care. With the appro

Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 17:18:00 EEST | Press release

Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522186975/en/ Adam Plich, CEO and Co-Founder of Avanzanite Bioscience. “Thalassaemia is a complex, chronic and multisystem disease characterised by anaemia, ineffective erythropoiesis and haemo

ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 15:30:00 EEST | Press release

OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future

Enhertu ® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 15:00:00 EEST | Press release

Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority

Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 14:45:00 EEST | Press release

Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, signalling a shift in health systems from late-stage treatment to earlier intervention. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522587414/en/ Selected from 393 submissions across 68 countries, the winning teams were recognised through the inaugural ‘Future Health Challenge 2026: Building Anticipatory Health Systems through Population Sensing’, delivered by Future Health – A Global Initiative by Abu Dhabi in collaboration with MIT Solve. Health systems globally are facing rising costs and persistent delays in diagnosis, with many conditions still identified only after symptoms become severe. At the sam

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye